Iaso Biodelivery was created with the sole focus to improve the lives of patients suffering from chronic diseases or under ineffective pharmacological treatments. The company develops new products using the technology of implantable drug delivery devices that introduce a therapeutic substance in the body and improve the safety and effectiveness of the drug by controlling the rate and region where it is released. Iaso Biodelivery works from the initial process of product development through to the prototype phase, which is then evaluated as to the possibility of manufacturing and commercializing the device by the company itself or for technology transfer to industries in the medical devices and pharmaceutical sectors.